"Biota managing director and chief executive Peter Cook said Tamiflu had long been the most popular choice for stockpiling. But Relenza would now make up about 30 per cent of the British stockpile, while other governments were likely to buy the drug when existing stocks reachedtheir five-year shelf life."
BTA Price at posting:
$1.47 Sentiment: Buy Disclosure: Held